AbbVie Inc. (United States)

AbbVie Inc. is a research-driven global biopharmaceutical company headquartered in North Chicago, Illinois. AbbVie develops breakthrough therapies in immunology, oncology, neuroscience, eye care, virology, and aesthetics. Best known for Humira (adalimumab) for autoimmune diseases, Skyrizi and Rinvoq for psoriasis and rheumatoid arthritis, Imbruvica for blood cancers, and Botox for cosmetic and therapeutic uses. AbbVie invests heavily in R&D to deliver innovative treatments for serious health conditions including Crohn’s disease, ulcerative colitis, and multiple myeloma.